Riskpilot← Back to searchSign inGet full accessBio L AB
ABActiveOrg 5590143334Fittja 51Veterinary activities · NACE 7500Est. 20152 employees
Revenue 2024
SEK 2,7M
+25% vs 2023
EBITDA margin
-9.3%
-183% vs 2023
Equity ratio
-42.4%
Financial strength
Net profit 2024
SEK -344K
-421% vs 2023
| Revenue | SEK 2,7M | +25% |
| EBITDA | SEK -248K | -183% |
| Net profit | SEK -344K | -421% |
| Total assets | SEK 676K | -10% |
| Equity | SEK -287K | -281% |
| Employees | 2 | — |
Legal name
Bio L AB
Org number
5590143334
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
20 maj 2015
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva medicinska-, veterinära och jordbrukstjänster. Behandlingar och professionell rådgivning till företag och privatpersoner. Biologisk agroforestry konsultation så som rådgivning och behandlingar för hantering kombinerat grödor och skogsplantering från ett biologiskt perspektiv till företag och privatpersoner.
Address
Fittja 51
Email
jcreytorres@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 654 | 2 088 | 2 090 | 2 122 | 2 655 |
| Staff expenses | — | — | −1 106 | −1 085 | −2 029 |
| EBITDA | 167 | 225 | 140 | 299 | −248 |
| Depreciation & amort. | −50 | −90 | −92 | −109 | −159 |
| EBIT | 117 | 135 | 48 | 190 | −407 |
| Net financials | −5 | −10 | −9 | −12 | −47 |
| Profit before tax | 38 | 122 | 66 | 136 | −344 |
| Tax | −9 | −26 | −15 | −29 | — |
| Net profit | 29 | 96 | 52 | 107 | −344 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 641 | 723 | 609 | 748 | 676 |
| Equity | 133 | 149 | 111 | 158 | −287 |
| Long-term debt | 0 | 149 | 0 | — | — |
| Short-term debt | 415 | 330 | 431 | 481 | 962 |
| Total debt | 415 | 479 | 431 | 481 | 962 |
EBITDA margin
-9.3%
This company
15.8%
Market median
-159% vs market
20202024
Equity ratio
-42.4%
This company
38.2%
Market median
-211% vs market
20202024
Return on equity
-34447700.0%
This company
18.4%
Market median
-187215861% vs market
20202024
Net profit margin
-13.0%
This company
8.1%
Market median
-260% vs market
20202024
Asset turnover
3.93×
This company
1.12×
Market median
+251% vs market
20202024
Debt / equity
3.36×
This company
0.62×
Market median
-442% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Bio L AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alejandra Sarmiento Soler | Deputy Board Member | 0 companies |
| Catalina Torres Soler | Deputy Board Member | 0 companies |
| Juan Carlos Rey Torres | Board of Directors | 0 companies |